Rajesh Malik insider trades: G1 Therapeutics (GTHX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Rajesh reports to the SEC
Open-market buys and sales
28 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 5, 2024 | GTHX | ↓ Sell | 2,475 | $2.51 | $6K | Direct | Jul 8, 2024 (3d) |
| May 13, 2024 | GTHX | ↓ Sell | 8,151 | $4.79 | $39K | Direct | May 15, 2024 (2d) |
| Feb 12, 2024 | GTHX | ↓ Sell | 28,600 | $4.62 | $132K | Direct | Feb 13, 2024 (1d) |
| Jan 4, 2024 | GTHX | ↓ Sell | 3,740 | $3.08 | $12K | Direct | Jan 8, 2024 (4d) |
| Dec 11, 2023 | GTHX | ↓ Sell | 33,839 | $3.41 | $116K | Direct | Dec 13, 2023 (2d) |
| Jul 5, 2023 | GTHX | ↓ Sell10b5-1 | 1,361 | $2.45 | $3K | Direct | Jul 7, 2023 (2d) |
| Jan 5, 2023 | GTHX | ↓ Sell | 2,368 | $5.52 | $13K | Direct | Jan 5, 2023 (0d) |
| Nov 28, 2022 | PNT | ↑ Buy | 3,700 | $6.66 | $25K | Direct | Nov 28, 2022 (0d) |
| Sep 13, 2022 | GTHX | ↓ Sell | 18,000 | $15.71 | $283K | Direct | Sep 16, 2022 (3d) |
| Jul 5, 2022 | GTHX | ↓ Sell | 648 | $5.17 | $3K | Direct | Jul 6, 2022 (1d) |
| Jan 5, 2022 | GTHX | ↓ Sell | 1,445 | $10.61 | $15K | Direct | Jan 5, 2022 (0d) |
| Apr 22, 2021 | GTHX | ↓ Sell | 15,000 | $22.07 | $331K | Direct | Apr 23, 2021 (1d) |
| Mar 23, 2021 | GTHX | ↓ Sell | 15,000 | $21.94 | $329K | Direct | Mar 24, 2021 (1d) |
| Mar 2, 2021 | GTHX | ↓ Sell | 15,000 | $22.95 | $344K | Direct | Mar 4, 2021 (2d) |
| Jan 22, 2021 | GTHX | ↓ Sell | 15,000 | $20.64 | $310K | Direct | Jan 22, 2021 (0d) |
| Dec 10, 2020 | GTHX | ↓ Sell | 9,000 | $20.06 | $181K | Direct | Dec 11, 2020 (1d) |
| Dec 17, 2018 | GTHX | ↓ Sell | 3,776 | $30.00 | $113K | Direct | Dec 17, 2018 (0d) |
| Nov 15, 2018 | GTHX | ↓ Sell | 3,776 | $39.75 | $150K | Direct | Nov 16, 2018 (1d) |
| Oct 15, 2018 | GTHX | ↓ Sell | 3,776 | $41.71 | $157K | Direct | Oct 15, 2018 (0d) |
| Sep 17, 2018 | GTHX | ↓ Sell | 3,776 | $66.08 | $250K | Direct | Sep 19, 2018 (2d) |
| Aug 15, 2018 | GTHX | ↓ Sell | 3,776 | $55.89 | $211K | Direct | Aug 17, 2018 (2d) |
| Jul 16, 2018 | GTHX | ↓ Sell | 3,776 | $42.17 | $159K | Direct | Jul 17, 2018 (1d) |
| Jun 15, 2018 | GTHX | ↓ Sell | 3,776 | $44.31 | $167K | Direct | Jun 18, 2018 (3d) |
| May 15, 2018 | GTHX | ↓ Sell | 3,776 | $46.30 | $175K | Direct | May 16, 2018 (1d) |
| Apr 16, 2018 | GTHX | ↓ Sell | 3,776 | $36.05 | $136K | Direct | Apr 17, 2018 (1d) |
| Mar 15, 2018 | GTHX | ↓ Sell | 3,776 | $38.18 | $144K | Direct | Mar 16, 2018 (1d) |
| Feb 15, 2018 | GTHX | ↓ Sell | 3,776 | $20.00 | $76K | Direct | Feb 16, 2018 (1d) |
| Jan 16, 2018 | GTHX | ↓ Sell | 3,776 | $22.96 | $87K | Direct | Jan 17, 2018 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Rajesh Malik's insider trades
Rajesh Malik is Chief Medical Officer at G1 Therapeutics (GTHX). Since Jan 16, 2018, Rajesh has reported 1 open-market purchase worth $25K and 27 sales worth $3.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
1 sale (0% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include option exercises (29 filings), grants and awards (12 filings), shares returned to the company (2 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GTHX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.